Prelude Therapeutics (PRLD) Amortizatization of Intangibles (2021 - 2026)

Prelude Therapeutics has disclosed Amortizatization of Intangibles across 6 years of filings, most recently posting $387000.0 for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $387000.0, up 589.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $837000.0 (down 79.81% YoY), and the FY2025 annual result was $371000.0, down 92.0% from the prior year.
• Amortizatization of Intangibles came in at $387000.0 for Q1 2026 at Prelude Therapeutics, up from $188000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $3.4 million in Q4 2024 to a low of -$3.6 million in Q3 2022.
• The 5-year median for Amortizatization of Intangibles is $397000.0 (2024), against an average of $278941.2.
• Across the five-year window, Amortizatization of Intangibles slumped 1114.61% in 2022 and jumped 589.87% in 2026, its largest moves.
• Prelude Therapeutics' Amortizatization of Intangibles stood at $179000.0 in 2022, then surged by 239.66% to $608000.0 in 2023, then soared by 465.13% to $3.4 million in 2024, then sank by 94.53% to $188000.0 in 2025, then jumped by 105.85% to $387000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $387000.0 (Q1 2026), $188000.0 (Q4 2025), and -$584000.0 (Q3 2025), per Business Quant data.